首页> 美国卫生研究院文献>Nephrology Dialysis Transplantation >Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial
【2h】

Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial

机译:低通气血液透析血液滤过和血液透析滤过患者的血红蛋白水平和对促红细胞生成剂的抵抗性的预测:一项多中心随机对照试验的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPredictors of haemoglobin (Hb) levels and resistance to erythropoiesis-stimulating agents (ESAs) in dialysis patients have not yet been clearly defined. Some mainly uncontrolled studies suggest that online haemodiafiltration (HDF) may have a beneficial effect on Hb, whereas no data are available concerning online haemofiltration (HF). The objectives of this study were to evaluate the effects of convective treatments (CTs) on Hb levels and ESA resistance in comparison with low-flux haemodialysis (HD) and to evaluate the predictors of these outcomes.
机译:背景尚未明确确定透析患者中​​血红蛋白(Hb)水平和对促红细胞生成剂(ESA)的耐药性的预测指标。一些主要不受控制的研究表明,在线血液透析滤过(HDF)可能对Hb有有益作用,而关于在线血液滤过(HF)的数据尚无。这项研究的目的是评估与低通量血液透析(HD)相比,对流治疗(CTs)对Hb水平和ESA抵抗的影响,并评估这些结果的预测因子。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号